Strategy of Innovation’s Management in the Pharmaceutical Industry Holds Intellectual Property - American Journal of Industrial and Business Management

AJIBM > Vol.3 No.6, October 2013

American Journal of Industrial and Business Management

Volume 3, Issue 6 (October 2013)

ISSN Print: 2164-5167 ISSN Online: 2164-5175

Google-based Impact Factor: 0.92 Citations

Strategy of Innovation’s Management in the Pharmaceutical Industry Holds Intellectual Property ()

HTML

Download as PDF (Size: 101KB) PP. 565-572

DOI: 10.4236/ajibm.2013.36065 5,348 Downloads 9,745 Views Citations

Author(s)

Cássia Rita Pereira da Veiga, Claudimar Pereira da Veiga, Jansen Maia Del Corso, Anderson Catapan

Affiliation(s)

.
Business School, Pontifical Catholic University of Paraná, Curitiba, Brazil..

ABSTRACT

In the management of innovation, intellectual property rights assume the primary role. In this sense, this paper aims to describe, with examples, the various strategies used by the pharmaceutical industry in the preservation of their legitimate rights of the intellectual property system. This is an exploratory study by using documentary research and longitudinal time. Even with the difference in laws between countries, the pharmaceutical anti-competitive practices gain more space in the global economy. For patents become political tools that foster innovation and diffusion of knowledge, it is suggested that revisions in the legislation, homogeneous international regulation and supervision of health authorities ensure quality of product and control of pharmaceutical marketing. This work also addresses political and social considerations on the subject while exploring some suggestions of ideal patent system.

KEYWORDS

Management of Innovation; Intellectual Property; Patent; Pharmaceutical Industry

Share and Cite:

C. Veiga, C. Veiga, J. Corso and A. Catapan, "Strategy of Innovation’s Management in the Pharmaceutical Industry Holds Intellectual Property," American Journal of Industrial and Business Management, Vol. 3 No. 6, 2013, pp. 565-572. doi: 10.4236/ajibm.2013.36065.

Cited by

[1]	Secondary patents in the pharmaceutical industry: Missing the wood for the trees?
	International Review of Sociology, 2018

[2]	Análises das capacidades dinâmicas no mercado farmacêutico
	2016

[3]	The correlation between the sustainability ratings of multi-national pharmaceutical corporations and new product development in middle to low-income countries
	ProQuest Dissertations Publishing, 2016

[4]	Evolution of Capabilities in the Discovery Cycle of an Innovation in the Pharmaceutical Market
	International Review of Management and Marketing, 2015

[5]	基于专利法对药品增量创新之评价研究
	科技管理研究, 2015

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies